Ardena is a global Contract Development and Manufacturing Organization (CDMO) and bioanalytical Contract Research Organization (CRO) based in Belgium. The company specializes in the development and manufacturing of innovative medicines, including small molecules, biologics, and nanomedicines. With seven sites across Belgium, The Netherlands, Sweden, Spain, and the United States, Ardena serves over 500 clients worldwide, including those in Europe, the US, Japan, and Korea.

Ardena offers a range of services that cover the entire drug development lifecycle. This includes drug substance development and GMP manufacturing, drug product development, and specialized nanomedicine services. The company also provides bioanalytical testing, solid-state chemistry expertise, and comprehensive CMC regulatory support. Their tailored project management ensures efficiency and alignment with clinical milestones, making Ardena a key partner in the pharmaceutical and biopharmaceutical sectors.